Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Epithelial to mesenchymal transition is associated with rapamycin resistance.

Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F.

Oncotarget. 2015 Aug 14;6(23):19500-13.

2.

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.

Hassan B, Akcakanat A, Sangai T, Evans KW, Adkins F, Eterovic AK, Zhao H, Chen K, Chen H, Do KA, Xie SM, Holder AM, Naing A, Mills GB, Meric-Bernstam F.

Oncotarget. 2014 Sep 30;5(18):8544-57.

3.

PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.

Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rashid A, Crosby K, Dong M, Phan AT, Wolff RA, Gupta S, Mills GB, Yao J.

Clin Cancer Res. 2012 Mar 15;18(6):1777-89. doi: 10.1158/1078-0432.CCR-11-2123.

4.

Triple-negative breast cancer is not a contraindication for breast conservation.

Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam F.

Ann Surg Oncol. 2011 Oct;18(11):3164-73. doi: 10.1245/s10434-011-1920-z. Epub 2011 Sep 27.

5.

Triple-negative breast cancer and obesity in a rural Appalachian population.

Vona-Davis L, Rose DP, Hazard H, Howard-McNatt M, Adkins F, Partin J, Hobbs G.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3319-24. doi: 10.1158/1055-9965.EPI-08-0544.

6.

Eliminating nosocomial infections at Ascension Health.

Berriel-Cass D, Adkins FW, Jones P, Fakih MG.

Jt Comm J Qual Patient Saf. 2006 Nov;32(11):612-20.

PMID:
17120920
7.

In vitro effects of pentosan polysulfate against malignant breast cells.

Zaslau S, Riggs DR, Jackson BJ, Adkins FC, John CC, Kandzari SJ, McFadden DW.

Am J Surg. 2004 Nov;188(5):589-92.

PMID:
15546576
8.

Observations on electrocorticographic effects of acetylcholine in monkeys and cats.

ESSIG CF, ADKINS FJ, BARNARD GL.

Proc Soc Exp Biol Med. 1953 Apr;82(4):551-3. No abstract available.

PMID:
13055930

Supplemental Content

Loading ...
Support Center